SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Salt'n'Peppa who wrote (8745)2/12/2002 11:44:14 AM
From: Salt'n'Peppa  Read Replies (1) | Respond to of 14101
 
*OT* FYI - label for Palmolive:

biosci.ohio-state.edu

(Half way down the page)
IRRITANT UPON DIRECT CONTACT.
SKIN: MAY CAUSE SKIN IRRITATION UPON PROLONGED CONTACT.
INGEST:IF YOU EAT/DRINK THIS, YOU MAY THROW UP.

Mmmmm, sounds familiar?
If Palmolive, with it's "may cause skin irritation" label was approved for widespread use, I don't think Pennsaid, with it's DMSO component, will be held back for same.

JMHO.
S&P


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News